Business Description
Theravance Biopharma is a California-based drug development company focused on creating treatments for serious respiratory and nervous system conditions. Its main product, YUPELRI, is a once-daily inhaled medication approved for patients with chronic obstructive pulmonary disease. The company is also advancing a promising experimental drug for a rare condition that causes dangerous drops in blood pressure, currently being tested in late-stage clinical trials. Founded in 2013, Theravance works alongside partner Viatris to bring its treatments to market.
